1
0
0
News
Die Mastozytose - Eine Erkrankung der hämopoetischen Stammzelle:...
www.aerzteblatt.de
Prof. Dr. med. Karl Sotlar Institut für Pathologie Ludwig-Maximilians-Universität München München Prof. Dr. med. Peter Valent Innere Medizin I (Hämatologie)
FIT Portfolio
fit.uni-tuebingen.de
Michael Bonin, Tanja Fehm, Jessica Hoffmann, Hans Neubauer, Olaf Horst Rieß, Karl Sotlar, Diethelm Wallwiener, Michael Walter
Antrittsvorlesung Prim. Univ.-Prof. Dr. Karl Sotlar | Salzburger...
salzburger-aerztegesellschaft.at
Mittwoch, 22. November :00 bis 21:00. Veranstaltungsort: Großer
Hörsaal ...
Artikel Deutsches Ärzteblatt
www.aerzteblatt.de
Aktuelles aus der Gesundheitspolitik, neueste Studien aus der medizinischen Forschung, Nachrichten aus der ärztlichen Berufspolitik und den Hochschulen
Netzwerk-Profile
WikiGenes - Karl Sotlar
www.wikigenes.org
Karl Sotlar. Institute of Pathology. University of Tübingen. . D Tübingen. Germany. [-tuebingen.de. Name/email ...
Ärzte & Mediziner
Systemic mastocytosis (SM) and associated malignant bone marrow...
www.termedia.pl
Systemic mastocytosis (SM) and associated malignant bone marrow histiocytosis – a hitherto undescribed form of SM-AHNMD. Zbigniew Rudzki, Karl Sotlar, ...
Business-Profile
Fachbeiräte – ÖGPath – Österreichische Abteilung der IAPoegpath.at › Die ÖGPath
oegpath.at
· Prim. Univ.Prof. Dr. Karl Sotlar. Universitätsinstitut für Pathologie Universitätsklinikum Salzburg. Lungen- und HNO-Pathologie. Priv.Doz.
Ausbildung
European Competence Network on Mastocytosis (ECNM) - Research Portal,...
kclpure.kcl.ac.uk
... and Oude-Elberink, {Hanneke N. G.} and Alberto Orfao and Deepti Radia and Andreas Reiter and Frank Siebenhaar and Karl Sotlar and Sperr, {Wolfgang R.} ...
Auszeichnungen
Priv.-Doz. Dr. Karl Sotlar, Institut für Pathologie, Tübingen -...
www.abitur-und-studium.de
Priv.-Doz. Dr. Karl Sotlar, Institut für Pathologie, Tübingen Artikel. Hohe wissenschaftliche Auszeichnung für Tübinger Pathologen
Bücher
Karl Sotlar - touchONCOLOGY
touchoncology.com
Authored Articles. >Contribution of the Prosigna® (PAM50) Gene Signature
Assay as ...
CLINICIAL, MORPHOLOGICAL AND GENETIC EVIDENCE FOR ...library.ehaweb.org › eha › juliana.schwaab.clinicial....
library.ehaweb.org
Karl Sotlar. ,. Karl Sotlar. Affiliations: Department of Pathology,University Hospital Salzburg, Paracelsus Medical University, Salzburg,Salzburg,Austria.
Oncostatin M Mediates STAT3-Dependent Intestinal Epithelial...
journals.plos.org
Karl Sotlar. Affiliation Institute of Pathology, Ludwig-Maximilians-University Munich, Munich, Germany. Burkhard Göke. Affiliation Department of ...
Hematopathology E-Book - Elaine Sarkin Jaffe, Nancy Lee Harris, James...
books.google.de
Introducing HEMATOPATHOLOGY, a definitive new diagnostic reference on diseases of the hematopoietic system by Dr. Elaine S. Jaffe and her fellow editors, all...
Dokumente zum Namen
Sotlar, Karl [WorldCat Identities]
worldcat.org
Most widely held works by Karl Sotlar. JAK2 V617F Mutationsanalysen an mikrodissektierten Zellen bei myeloproliferativen Neoplasien by Leonie ...
EBSCOhost | | Necrotizing fasciitis in a young patient with...
web.a.ebscohost.com
-muenchen.de. Karl Sotlar muenchen.de. Ekkehard Euler muenchen.de.
Wissenschaftliche Veröffentlichungen
DFG - GEPRIS - Professor Dr. Karl Sotlar
gepris.dfg.de
Professor Dr. Karl Sotlar, Pathologisches InstitutMünchen
Osteonecrosis of the jaw as a possible rare side effect of annual...
jmedicalcasereports.biomedcentral.com
Osteonecrosis of the jaw is a serious side effect in patients receiving nitrogen-containing bisphosphonates intravenously due to malignant diseases. Albeit far...
Protective mucosal immunity mediated by epithelial CD1d and IL-10. |...
www.ikmb.uni-kiel.de
ikmb - Institut für ... » Protective mucosal immunity mediated by epithelial CD1d and IL Chyuan-Sheng Lin, Christian Jobin, Stephan Brand, Karl Sotlar ...
Professor Dr. Karl Sotlar
gepris.dfg.de
Professor Dr. Karl Sotlar Als Antragsteller abgeschlossene Projekte Implementierung von Paraffingewebe zur Evaluation von Genexpressionsprofilen beim DCIS der
Veröffentlichungen allgemein
Hematological Malignancies | Magdalena Czader | Springer
link.springer.com
Increased knowledge on the pathogenesis of hematologic diseases has been translated into diagnostic and prognostic applications. Hematopathology and...
World Journal of Surgical Oncology - BioMedSearch
www.biomedsearch.com
-tuebingen.de; Karl Sotlar - - tuebingen.de; Wolfgang Steurer - -tuebingen.de; ...
Oalib search
www.oalib.com
Abstract: We report the case of a 65-year-old Caucasian woman suffering from osteoporosis who developed early stage osteonecrosis of ...
Mastozytose | SpringerLink
link.springer.com
Karl Sotlar. Institut für PathologieKlinikum der Universität München. Kompetenznetzwerk Mastozytose e.V.. Leitlinie / Guideline. First Online:
Artikel & Meinungen
Protective mucosal immunity mediated by epithelial CD1d and IL-10 |...
www.nature.com
Here, the presentation of lipid antigens by CD1d is shown to induce retrograde anti-inflammatory signalling in intestinal epithelial cells, resulting in the...
Aberrant expression of CD30 in neoplastic mast cells in high-grade...
www.nature.com
Original Article
Sonstiges
SALK: Chirurgie und Pathologie unter neuer Leitung - Salzburg-Stadt
www.meinbezirk.at
Klaus Emmanuel, Karl Sotlar, SALK-Geschäftsführer Paul Sungler, Gesundheits- und Spitalsreferent LHstv. Christian Stöckl und der 1. Oberarzt der Uniklinik
Karl Sotlar - German pathologist - Prabookprabook.com › web › karl.sotlar
prabook.com
Karl Sotlar, German pathologist. Achievements include research in one-step detection of c-kit point mutations using PNA-mediated polymerase chain ...
DFP-Kalender
www.dfpkalender.at
Salzburger Landeskliniken, SALK St. Johanns-Spital/LKH Sbg., Paracelsus Univ.Univ.-Klinik für Innere Medizin II, Kardiologie u. Int. Intensivmed.
GMS | 27. Deutscher Krebskongress | Breast cancer proteomics by laser...
www.egms.de
Karl Sotlar - Department of Pathology, University of Tuebingen, Germany Alfred Nordheim - Department of Molecular Biology and Proteome Center, Institute for Cell Biology, University of Tuebingen, Germany André Schrattenholz - ProteoSys AG, …
Decision Impact Studien BCIST und PRIMe und PROTROCA. Dr. med. Rachel...
docplayer.org
... A: 63,1% Luminal B: 35,8% Low-risk: 42,9%; High-risk: 21,7% Intermediate risk : 35,4% March 18, courtesy of Prof. Karl Sotlar, Munich WSG GmbH 20.
GMS | 27th German Cancer Congress Berlin | Raman spectroscopy to...
www.egms.de
Karl Sotlar - Department of Pathology, University of Tübingen Tanja Fehm - Department of Obstetrics and Gynecology, University of Tübingen Erich Solomayer ...
First step - start of the internal trial
forschungsberichte.charite.de
Karl Sotlar Burkhard Bültmann [4] -tuebingen.de -tuebingen.de Molekulare Diagnostik , Institut für Klinische Pathologie,
Clinical and histopathological features of myeloid neoplasms with ...eprints.soton.ac.uk › ...
eprints.soton.ac.uk
Author: Karl Sotlar. Author: Claire Oni. Author: Claire Harrison. Author: Wolf-Karsten Hofmann. Author: Nicholas Cross · ORCID iD. Author: Peter Valent.
Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from...
hal.archives-ouvertes.fr
Peter Valent, Wolfgang Kern, Gregor Hoermann, Jelena Milosevic Feenstra, Karl Sotlar, et al.. Clonal Hematopoiesis with Oncogenic Potential (CHOP): ...
Contemporary consensus proposal on criteria and classification of...
mayoclinic.pure.elsevier.com
... Joseph H. Butterfield, Wolfgang R. Sperr, Karl Sotlar, Peter Vandenberghe, Torsten Haferlach, Hans Uwe Simon, Andreas Reiter, Gerald J. Gleich.
Uniklinikum Journal. Heilung mit Hightech WISSENSWERT SALZBURGER...
docplayer.org
Mit dem Next-Generation-Sequencing (NGS) steht uns eine höchst innovative und moderne Technologie zur Verfügung, sagt Pathologe Prof. Karl Sotlar, die wir ...
IJMS | Free Full-Text | Clonal Hematopoiesis with Oncogenic Potential...
www.mdpi.com
Milosevic Feenstra 2 , Karl Sotlar 6, Michael Pfeilstöcker 2,7, Ulrich ...
Internet Scientific Publications
ispub.com
University Children's HospitalD Tübingen, Germany. Karl Sotlar, PhD. University of Tübingen, Institute of Pathology, Calwerstr.3, ...
MCAD > Mastzellerkrankungen > Krankheitsmechanismus
www.mastzellaktivierung.info
MCAD Infoseite | Krankheitsmechanismus und Ursachen der Mastzellaktivierungserkrankungen detailliert erklärt. Biochem. Grundlagen
MSH2 and CXCR4 involvement in malignant VIPoma – topic of research...
cyberleninka.org
... paper in Clinical medicine , author of scholarly article — Sven Müller, Susan Kupka, Ingmar Königsrainer, Hinnak Northoff, Karl Sotlar, et al.
Molecular and protein markers for clinical decision making in breast...
pubmed.ncbi.nlm.nih.gov
2014 Apr;40(3): doi: j.ctrv Epub Sep 29. Authors. Nadia Harbeck , Karl Sotlar , Rachel Wuerstlein , Sophie Doisneau-Sixou ...
Pathogenesis and classification of eosinophil disorders: A review of ...www.scholars.northwestern.edu › fingerprints
www.scholars.northwestern.edu
... Michel Arock, Karl Sotlar, Joseph H. Butterfield, Sabine Cerny-Reiterer, Matthias Mayerhofer, Peter Vandenberghe, Torsten Haferlach, Bruce S. Bochner, ...
Prosigna®-Genexpressionstest: Prognosebestimmung beim frühen...
www.medmedia.at
Mammakarzinom. AutorIn: Karl Sotlar • Focus: Jahrestagung ...
Rudolf-Virchow-Stiftung - Deutsche Gesellschaft für Pathologie
www.pathologie-dgp.de
PD Dr. med. Karl Sotlar Tübingen:
Volume 9, Issue jca
www.jcancer.org
Andrea Herold, Gerald Assmann, Jan Budczies, Karl Sotlar, Thomas Kirchner
sortiert nach Relevanz / Datum